Short Summary
UiPath's IPR challenge against Rule 14 LLC was denied by the PTAB, as the Petitioner failed to demonstrate a reasonable likelihood of prevailing on any challenged claims. The Board rejected the obviousness arguments because UiPath relied on conclusory assertions regarding motivation-to-combine rather than factual support.
Detailed Summary
The Patent Trial and Appeal Board (PTAB) issued an institution decision denying IPR2024-01306, where Petitioner UiPath, Inc., challenged patent number 11048712 owned by Rule 14 LLC. The grounds for the challenge were based on obviousness under 35 U.S.C. § 103. Although UiPath presented arguments combining various prior art references (including Kirsch, Schultz, and Lucovsky) to show that the claims were obvious, the Board found these assertions insufficient. Specifically, the Petitioner failed to establish a reasonable likelihood of prevailing because its motivation-to-combine reasoning was deemed conclusory and lacked necessary factual backing, leading to the denial of institution for all challenged claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in UiPath, Inc. vs Rule 14 LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Yealink (USA) Network Technology Co., Ltd. et al.vsBarco N.V.
Yealink successfully petitioned to challenge several claims of Barco's patent (11258676) based on obviousness over prior art references Ono and Deforche. The PTAB granted institution, finding a reasonable likelihood that the petitioner would prevail in establishing unpatentability for Claim 1.
OneSource Solutions International, Inc. et al.vsHippocratic AI, Inc.
The USPTO Director denied OneSource Solutions' request for Director Review of the denial to institute a PGR against Hippocratic AI's patent 12,142,371. The original institution denial therefore remains in effect.
Volex plcvsCREDO TECHNOLOGY GROUP LTD.
Volex plc and Credo Technology Group Ltd. have settled their IPR dispute over U.S. Patent 11,032,111 and jointly request that the settlement agreement be kept confidential and the proceeding terminated.
Azurity Pharmaceuticals, Inc.vsEXELIXIS, INC.
Azurity has filed an IPR petition seeking cancellation of all 22 claims of Exelixis’s U.S. 12,128,039 patent, arguing obviousness over Brown combined with Kubo and Robinson references.
Meta Platforms, Inc.vsSitNet, LLC
Meta Platforms petitions the PTAB to invalidate all twelve claims of SitNet’s U.S. Patent 12,336,052, asserting obviousness over two sets of prior‑art references covering social‑network event handling. The petition seeks cancellation of the entire patent.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.